Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.

Corinne Bosquet; Justano Castaño; Zsolt Csaba; Micheal Culler; Pascal Dournaud; Jacques  Epelbaum; Wasyl  Feniuk; Anthony Harmar; Rebecca Hills; Leo Hofland; Daniel Hoyer; Patrick Humphrey; Hans-Jürgen Kreienkamp; Amelie Lupp; Shlomo Melmed; Wolfgang Meyerhof; Anne-Marie O'Carroll; Yogesh Patel; Terry Reisine; Jean-Claude Reubi; Marcus Schindler; Herbert Schmid; Agnes Schonbrunn; Stefan Schulz; John Taylor; Giovanni Tulipano; Annamaria Vezzani; Hans-Jürgen  Wester

doi:10.2218/gtopdb/F61/2019.4

Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.

Corinne Bosquet, Justano Castaño, Zsolt Csaba, Micheal Culler, Pascal Dournaud, Jacques Epelbaum, Wasyl Feniuk, Anthony Harmar, Rebecca Hills, Leo Hofland, Daniel Hoyer, Patrick Humphrey, Hans-Jürgen Kreienkamp, Amelie Lupp, Shlomo Melmed, Wolfgang Meyerhof, Anne-Marie O'Carroll, Yogesh Patel, Terry Reisine, Jean-Claude ReubiMarcus Schindler, Herbert Schmid, Agnes Schonbrunn, Stefan Schulz, John Taylor, Giovanni Tulipano, Annamaria Vezzani, Hans-Jürgen Wester

Research output: Contribution to journal › Article (Academic Journal) › peer-review

140 Downloads (Pure)

Abstract

Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors

Original language	English
Number of pages	17
Journal	IUPHAR/BPS Guide to PHarmacology CITE
DOIs	https://doi.org/10.2218/gtopdb/F61/2019.4
Publication status	Published - 16 Sept 2019

Access to Document

10.2218/gtopdb/F61/2019.4

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via IUPHAR/BPS at http://journals.ed.ac.uk/gtopdb-cite/article/view/3213. Please refer to any applicable terms of use of the publisher.
Final published version, 201 KBLicence: CC BY-SA

Handle.net

Persistent link

Embargoed Document

Full-text PDF (accepted author manuscript)
Accepted author manuscript, 357 KB

Cite this

Bosquet, C., Castaño, J., Csaba, Z., Culler, M., Dournaud, P., Epelbaum, J., Feniuk, W., Harmar, A., Hills, R., Hofland, L., Hoyer, D., Humphrey, P., Kreienkamp, H.-J., Lupp, A., Melmed, S., Meyerhof, W., O'Carroll, A.-M., Patel, Y., Reisine, T., ... Wester, H.-J. (2019). Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to PHarmacology CITE. https://doi.org/10.2218/gtopdb/F61/2019.4

@article{a8830ac1e247487a9b3929f5449a0670,

title = "Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.",

abstract = "Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors",

author = "Corinne Bosquet and Justano Casta{\~n}o and Zsolt Csaba and Micheal Culler and Pascal Dournaud and Jacques Epelbaum and Wasyl Feniuk and Anthony Harmar and Rebecca Hills and Leo Hofland and Daniel Hoyer and Patrick Humphrey and Hans-J{\"u}rgen Kreienkamp and Amelie Lupp and Shlomo Melmed and Wolfgang Meyerhof and Anne-Marie O'Carroll and Yogesh Patel and Terry Reisine and Jean-Claude Reubi and Marcus Schindler and Herbert Schmid and Agnes Schonbrunn and Stefan Schulz and John Taylor and Giovanni Tulipano and Annamaria Vezzani and Hans-J{\"u}rgen Wester",

year = "2019",

month = sep,

day = "16",

doi = "10.2218/gtopdb/F61/2019.4",

language = "English",

journal = "IUPHAR/BPS Guide to PHarmacology CITE",

issn = "2633-1020",

publisher = "Edinburgh University Library",

}

Bosquet, C, Castaño, J, Csaba, Z, Culler, M, Dournaud, P, Epelbaum, J, Feniuk, W, Harmar, A, Hills, R, Hofland, L, Hoyer, D, Humphrey, P, Kreienkamp, H-J, Lupp, A, Melmed, S, Meyerhof, W, O'Carroll, A-M, Patel, Y, Reisine, T, Reubi, J-C, Schindler, M, Schmid, H, Schonbrunn, A, Schulz, S, Taylor, J, Tulipano, G, Vezzani, A & Wester, H-J 2019, 'Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.', IUPHAR/BPS Guide to PHarmacology CITE. https://doi.org/10.2218/gtopdb/F61/2019.4

TY - JOUR

T1 - Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.

AU - Bosquet, Corinne

AU - Castaño, Justano

AU - Csaba, Zsolt

AU - Culler, Micheal

AU - Dournaud, Pascal

AU - Epelbaum, Jacques

AU - Feniuk, Wasyl

AU - Harmar, Anthony

AU - Hills, Rebecca

AU - Hofland, Leo

AU - Hoyer, Daniel

AU - Humphrey, Patrick

AU - Kreienkamp, Hans-Jürgen

AU - Lupp, Amelie

AU - Melmed, Shlomo

AU - Meyerhof, Wolfgang

AU - O'Carroll, Anne-Marie

AU - Patel, Yogesh

AU - Reisine, Terry

AU - Reubi, Jean-Claude

AU - Schindler, Marcus

AU - Schmid, Herbert

AU - Schonbrunn, Agnes

AU - Schulz, Stefan

AU - Taylor, John

AU - Tulipano, Giovanni

AU - Vezzani, Annamaria

AU - Wester, Hans-Jürgen

PY - 2019/9/16

Y1 - 2019/9/16

N2 - Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors

AB - Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors

U2 - 10.2218/gtopdb/F61/2019.4

DO - 10.2218/gtopdb/F61/2019.4

M3 - Article (Academic Journal)

SN - 2633-1020

JO - IUPHAR/BPS Guide to PHarmacology CITE

JF - IUPHAR/BPS Guide to PHarmacology CITE

ER -

Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.

Abstract

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this